We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Study Shows First-Trimester MRI Does Not Increase Risk of Stillborn Babies

By HospiMedica International staff writers
Posted on 19 Sep 2016
A new study has found that undergoing a Magnetic Resonance Imaging (MRI) exam during the first trimester of pregnancy does not increase a woman’s risk of having a stillborn baby.

In addition, the study showed that a baby does not have an increased risk of having a birth defect, or dying soon after birth. More...
The children do not have an increased risk of vision or hearing loss, or cancer, in the first four years of their life.

This is one of the first controlled studies on the safety of MRIs for fetuses in the first trimester of pregnancy. MRIs are already considered safe for use in the second and third trimesters of pregnancy.

The results of the study were published online in the September 6, 2016, issue of the journal JAMA. The researchers from St. Michael Hospital (Toronto, ON, Canada) examined the records of over 1.4 million births in Ontario, Canada between 2003 and 2015 and compared women who had undergone MRIs in the first-trimester of their pregnancy with those that had not. The researchers continued to track the health of the children until they reached the age of four.

The study also found that in Ontario, Canada, one out of 250 pregnant women have an MRI exam sometime during their pregnancy, and one out of 1,200 women have an MRI exam in the first trimester.

The researchers did find a slightly elevated risk of stillbirth, or neonatal death, when women underwent a gadolinium-enhanced MRI exam, and a slightly higher risk of rheumatologic or skin condition in their children. The results support clinical guidelines advising pregnant women to avoid gadolinium-enhanced MRI exams unless strongly indicated.

Related Links:
St. Michael Hospital


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Fetal Monitor
BT-380
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.